Zogenix Inc (ZGNX)

9.33
NASDAQ : Health Care
Prev Close 9.33
Day Low/High 0.00 / 0.00
52 Wk Low/High 7.33 / 21.03
Avg Volume 153.80K
Exchange NASDAQ
Shares Outstanding 24.79M
Market Cap 230.31M
EPS 1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Commit To Buy Zogenix At $5, Earn 9.6% Annualized Using Options

Commit To Buy Zogenix At $5, Earn 9.6% Annualized Using Options

Investors eyeing a purchase of Zogenix Inc. stock, but cautious about paying the going market price of $8.98/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Zogenix Becomes Oversold (ZGNX)

Zogenix Becomes Oversold (ZGNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Zogenix Provides Corporate Update And Reports First Quarter 2016 Financial Results

Zogenix Provides Corporate Update And Reports First Quarter 2016 Financial Results

Company will host a conference call today at 4:30 p.m. EDT/1:30 p.m. PDT

New Data On Zogenix's ZX008 For Dravet Syndrome To Be Presented At 14th International Child Neurology Congress

New Data On Zogenix's ZX008 For Dravet Syndrome To Be Presented At 14th International Child Neurology Congress

Podium Presentation to Highlight Efficacy, Cardiovascular Safety, Sleep Quality, and Quality of Life in Patients Receiving Low-Dose Fenfluramine for the Treatment of Dravet Syndrome

ZGNX: Insiders vs. Shorts

ZGNX: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 03/01/2016 settlement date, and Zogenix Inc. is one of the most shorted stocks of the Russell 3000, based on 18.11 "days to cover" versus the median component at 5.60.

Zogenix (ZGNX): Today's Weak On High Volume Stock

Zogenix (ZGNX): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Zogenix (ZGNX) as a weak on high relative volume candidate

Zogenix Provides Corporate Update And Reports Fourth Quarter And Full-Year 2015 Financial Results

Zogenix Provides Corporate Update And Reports Fourth Quarter And Full-Year 2015 Financial Results

Company will host a conference call today at 4:30 p.m. EST/1:30 p.m. PST

Commit To Buy Zogenix At $8, Earn 23.1% Using Options

Commit To Buy Zogenix At $8, Earn 23.1% Using Options

Investors considering a purchase of Zogenix Inc. shares, but cautious about paying the going market price of $10.25/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Insider Trading Alert - SCVL, ZGNX And FRME Traded By Insiders

Insider Trading Alert - SCVL, ZGNX And FRME Traded By Insiders

Stocks with insider trader activity include SCVL, ZGNX and FRME

Insider Trading Alert - RNST, AMPH And ZGNX Traded By Insiders

Insider Trading Alert - RNST, AMPH And ZGNX Traded By Insiders

Stocks with insider trader activity include RNST, AMPH and ZGNX

Zogenix Announces New Efficacy And Safety Data On ZX008 For Treatment Of Seizures In Dravet Syndrome

Zogenix Announces New Efficacy And Safety Data On ZX008 For Treatment Of Seizures In Dravet Syndrome

New Clinical Data Presented at 69th Annual American Epilepsy Society Meeting on the Use of Low-Dose Fenfluramine in Managing Seizures Associated With Dravet Syndrome

Zogenix Provides Corporate Update And Reports Third Quarter 2015 Financial Results

Zogenix Provides Corporate Update And Reports Third Quarter 2015 Financial Results

Company Will Host a Conference Call Today at 4:30 p.m. EST/1:30 p.m. PST

Zogenix Provides Regulatory Update For ZX008

Zogenix Provides Regulatory Update For ZX008

Company Continues to Expect Phase 3 Clinical Program to Begin in Fourth Quarter of 2015

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts

These stocks look ready to break out and trade higher from current levels.